Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
Researchers at MIT developed injectable nanoantennas that can be wirelessly activated to kill drug-resistant brain cancer cells. The technology, called HITMAN, uses magnetic fields to create electric fields that target tumors without harming healthy tissue. Early tests showed it was more effective than standard chemotherapy in killing cancer cells in the lab.
MIT researchers created nanoantennas that can be activated with magnets to kill brain cancer cells. The devices target tumors without harming healthy brain tissue and showed better results than standard chemotherapy in lab tests.
This technology could offer a new, more effective treatment for a deadly form of brain cancer that is hard to treat. It provides a safer and more targeted approach, which could improve patient outcomes and quality of life.
The development shows how innovative science can address serious health challenges. It offers hope for patients and highlights the potential of nanotechnology in medicine.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.